Kevin Shannon

Age-Related Ventricular Tachycardia Substrate Characteristics for Repaired Tetralogy of Fallot Before Transcatheter Pulmonary Valve Placement

<i>In Vivo</i> and <i>In Vitro</i> Chemical Synthetic Lethality of ABHD17 and MEK Inhibition in <i>NRAS</i>-Mutant Acute Myeloid Leukemia

RASA2 ablation in T cells boosts antigen sensitivity and long-term function

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease

ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth

Permanent conduction system pacing for congenitally corrected transposition of the great arteries: A Pediatric and Congenital Electrophysiology Society (PACES)/International Society for Adult Congenital Heart Disease (ISACHD) Collaborative Study

Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome

Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice

KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice

Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes

Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1

AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells

Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer

Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy

KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer

The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia

Clinical Experience With the Subcutaneous Implantable Cardioverter–Defibrillator in Adults With Congenital Heart Disease

Catheter ablation of supraventricular tachyarrhythmia after extracardiac Fontan surgery

KRAS Engages AGO2 to Enhance Cellular Transformation

Somatic and Germline <i>TP53</i> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis

MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia

Preclinical efficacy of MEK inhibition in Nras-mutant AML

Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia

Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation

Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in <i>Nras-</i> Driven Hematopoietic Transformation